“Secukinumab Reduces Endothelial Dysfunction in Subjects With Moderate-to-Severe Plaque Psoriasis Over 52 Weeks: Results of the Exploratory CARIMA Study”. 2018. SKIN The Journal of Cutaneous Medicine 2 (S1): S20. https://doi.org/10.25251/skin.2.supp.20.